Literature DB >> 28496830

Role of Intracardiac echocardiography in Atrial Fibrillation Ablation.

Antonio Dello Russo1, Eleonora Russo1, Gaetano Fassini1, Michela Casella1, Ester Innocenti1, Martina Zucchetti1, Claudia Cefalu1, Francesco Solimene2, Gaetano Mottola2, Daniele Colombo1, Fabrizio Bologna1, Benedetta Majocchi1, Pasquale Santangeli3, Stefania Riva1, Luigi Di Biase3, Cesare Fiorentini1, Claudio Tondo1.   

Abstract

In the recent years, several new evidences support catheter-based ablation as a treatment modality of atrial fibrillation (AF). Based on a plenty of different applications, intracardiac echocardiography (ICE) is now a well-established technology in complex electrophysiological procedures, in particular in AF ablation. ICE contributes to improve the efficacy and safety of such procedures defining the anatomical structures involved in ablation procedures and monitoring in real time possible complications. In particular ICE allows: a correct identification of the endocardial structures; a guidance of transseptal puncture; an assessment of accurate placement of the circular mapping catheter; an indirect evaluation of evolving lesions during radiofrequency (RF) energy delivery via visualization of micro and macrobubbles tissue heating; assessment of catheter contact with cardiac tissues. Recently, also the feasibility of the integration of electroanatomical mapping (EAM) and intracardiac echocardiography has been demonstrated, combining accurate real time anatomical information with electroanatomical data. As a matter of fact, different techniques and ablation strategies have been developed throughout the years. In the setting of balloon-based ablation systems, recently adopted by an increasing number of centers, ICE might have a role in the choice of appropriate balloon size and to confirm accurate occlusion of pulmonary veins. Furthermore, in the era of minimally fluoroscopic ablation, ICE has successfully provided a contribute in reducing fluoroscopy time. The purpose of this review is to summarize the current applications of ICE in catheter based ablation strategies of atrial fibrillation, focusing-on electronically phased-array ICE.

Entities:  

Year:  2013        PMID: 28496830      PMCID: PMC5153176          DOI: 10.4022/jafib.786

Source DB:  PubMed          Journal:  J Atr Fibrillation        ISSN: 1941-6911


  55 in total

1.  Point-by-point pulmonary vein antrum isolation guided by intracardiac echocardiography and 3D mapping and duty-cycled multipolar AF ablation: effect of multipolar ablation on procedure duration and fluoroscopy time.

Authors:  Yaariv Khaykin; Lauren Zarnett; Daniel Friedlander; Zaev A Wulffhart; Bonnie Whaley; David Giewercer; Bernice Tsang; Atul Verma
Journal:  J Interv Card Electrophysiol       Date:  2012-03-11       Impact factor: 1.900

2.  Fossa ovalis radiofrequency perforation in a difficult case of conventional transseptal puncture for atrial fibrillation ablation.

Authors:  Michela Casella; Antonio Dello Russo; Gemma Pelargonio; Annamaria Martino; Stefano De Paulis; Paolo Zecchi; Fulvio Bellocci; Claudio Tondo
Journal:  J Interv Card Electrophysiol       Date:  2008-02-15       Impact factor: 1.900

3.  First human experience with real-time integration of intracardiac echocardiography and 3D electroanatomical imaging to guide right free wall accessory pathway ablation.

Authors:  Yaariv Khaykin; Ofer Klemm; Atul Verma
Journal:  Europace       Date:  2007-11-13       Impact factor: 5.214

4.  Use of a novel sharp-tip, J-shaped guidewire to facilitate transseptal catheterization.

Authors:  Roberto De Ponti; Raffaella Marazzi; Giuseppe Picciolo; Jorge A Salerno-Uriarte
Journal:  Europace       Date:  2010-03-12       Impact factor: 5.214

5.  2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design: a report of the Heart Rhythm Society (HRS) Task Force on Catheter and Surgical Ablation of Atrial Fibrillation. Developed in partnership with the European Heart Rhythm Association (EHRA), a registered branch of the European Society of Cardiology (ESC) and the European Cardiac Arrhythmia Society (ECAS); and in collaboration with the American College of Cardiology (ACC), American Heart Association (AHA), the Asia Pacific Heart Rhythm Society (APHRS), and the Society of Thoracic Surgeons (STS). Endorsed by the governing bodies of the American College of Cardiology Foundation, the American Heart Association, the European Cardiac Arrhythmia Society, the European Heart Rhythm Association, the Society of Thoracic Surgeons, the Asia Pacific Heart Rhythm Society, and the Heart Rhythm Society.

Authors:  Hugh Calkins; Karl Heinz Kuck; Riccardo Cappato; Josep Brugada; A John Camm; Shih-Ann Chen; Harry J G Crijns; Ralph J Damiano; D Wyn Davies; John DiMarco; James Edgerton; Kenneth Ellenbogen; Michael D Ezekowitz; David E Haines; Michel Haissaguerre; Gerhard Hindricks; Yoshito Iesaka; Warren Jackman; José Jalife; Pierre Jais; Jonathan Kalman; David Keane; Young-Hoon Kim; Paulus Kirchhof; George Klein; Hans Kottkamp; Koichiro Kumagai; Bruce D Lindsay; Moussa Mansour; Francis E Marchlinski; Patrick M McCarthy; J Lluis Mont; Fred Morady; Koonlawee Nademanee; Hiroshi Nakagawa; Andrea Natale; Stanley Nattel; Douglas L Packer; Carlo Pappone; Eric Prystowsky; Antonio Raviele; Vivek Reddy; Jeremy N Ruskin; Richard J Shemin; Hsuan-Ming Tsao; David Wilber
Journal:  Heart Rhythm       Date:  2012-03-01       Impact factor: 6.343

6.  Transseptal access and atrial fibrillation ablation guided by intracardiac echocardiography in patients with atrial septal closure devices.

Authors:  Pasquale Santangeli; Luigi Di Biase; J David Burkhardt; Rodney Horton; Javier Sanchez; Shane Bailey; Jason D Zagrodzky; Dhanunjaya Lakkireddy; Rong Bai; Prasant Mohanty; Salwa Beheiry; Richard Hongo; Andrea Natale
Journal:  Heart Rhythm       Date:  2011-06-22       Impact factor: 6.343

7.  Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study.

Authors:  Claudia Herrera Siklódy; Thomas Deneke; Mélèze Hocini; Heiko Lehrmann; Dong-In Shin; Shinsuke Miyazaki; Susanne Henschke; Peter Fluegel; Jochen Schiebeling-Römer; Paul M Bansmann; Thomas Bourdias; Vincent Dousset; Michel Haïssaguerre; Thomas Arentz
Journal:  J Am Coll Cardiol       Date:  2011-06-12       Impact factor: 24.094

8.  Cryoballoon pulmonary vein isolation supported by intracardiac echocardiography: integration of a nonfluoroscopic imaging technique in atrial fibrillation ablation.

Authors:  Georg Nölker; Johannes Heintze; Klaus-Jürgen Gutleben; Bogdan Muntean; Vanessa Pütz; Ameera Yalda; Jürgen Vogt; Dieter Horstkotte
Journal:  J Cardiovasc Electrophysiol       Date:  2010-12

9.  Real-time rotational ICE imaging of the relationship of the ablation catheter tip and the esophagus during atrial fibrillation ablation.

Authors:  Adam Helms; J Jason West; Amit Patel; J Paul Mounsey; John P DiMarco; J Michael Mangrum; John D Ferguson
Journal:  J Cardiovasc Electrophysiol       Date:  2008-09-03

10.  Ablation of atrial tachycardias after correction of complex congenital heart diseases: utility of intracardiac echocardiography.

Authors:  Petr Peichl; Josef Kautzner; Roman Gebauer
Journal:  Europace       Date:  2008-11-23       Impact factor: 5.214

View more
  2 in total

Review 1.  Transseptal Access to the Left Atrium: Tips and Tricks to Keep it Safe Derived from Single Operator Experience and Review of the Literature.

Authors:  Antonis S Manolis
Journal:  Curr Cardiol Rev       Date:  2017

2.  The use of intracardiac echocardiography catheters in endocardial ablation of cardiac arrhythmia: Meta-analysis of efficiency, effectiveness, and safety outcomes.

Authors:  Masahiko Goya; Diana Frame; Larry Gache; Yoko Ichishima; Daiane Oliveira Tayar; Laura Goldstein; Stephanie Hsiao Yu Lee
Journal:  J Cardiovasc Electrophysiol       Date:  2020-01-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.